Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Immature Platelet Fraction and Acute Coronary Syndrome; a Systematic Review and Meta-Analysis Publisher



E Jafari Afshar ELMIRA ; V Shahnavaz VAHID ; H Talakoob HAMED ; P Kafialqora PARNAZ ; A Madady ARYAN ; S Pourbahrighesmat SHAMIMEH ; A Tayebi AMIRHOSSEIN ; Mhm Bazargany Mohammad Hossein MOZAFARY ; N Gholami NILOOFAR ; A Ayati ARYAN
Authors

Source: Archives of Academic Emergency Medicine Published:2024


Abstract

Introduction: Immature Platelet Fraction (IPF) is a measure of the proportion of reticulated platelets (RPs) to all platelets in circulation. IPF may have both prognostic and diagnostic values in patients with Acute Coronary Syndrome (ACS). This study aims to comprehensively summarize the diagnostic utility of IPF levels in patients with ACS, specifically focusing on its ability to differentiate between different subtypes of ACS. Methods: We conducted a systematic search in online databases including MEDLINE, Scopus, and Google Scholar up to March 4th 2024, to identify relevant studies. The random-effect model, employing inverse variance for mean differences (MD) and Mantel-Haenszel methods for odds ratios (OR) were utilized to combine the data. Joanna Briggs Institute (JBI) appraisal tool was employed to assess the quality of included studies. Results: Our systematic review contains 15 articles with a total sample size of 2,030 ACS patients. Pooled analysis revealed significant differences in IPF levels of ACS patients compared to healthy controls (MD (95%CI): 2.85 (0.86, 4.85), P-value = 0.004) and stable angina patients (MD (95%CI): 0.58 (0.23, 0.92), P-value < 0.001). Subgroup comparisons within ACS patients demonstrated higher IPF levels in myocardial infarction (MI) vs. unstable angina (UA) (MD (95%CI): 1.81 (0.41, 3.22), P-value = 0.01), ST elevation MI (STEMI) vs. non-ST elevation (NSTEMI) ACS (MD (95%CI): 0.74 (0.31, 1.17), P-value < 0.001), and NSTEMI vs. UA (MD (95% CI): 1.07 (0.24, 1.90), P-value = 0.01). Conclusion: IPF levels could increase in patients with ACS, particularly during the acute phase of STEMI. This suggests that IPF may be a useful biomarker for early diagnosis of ACS. Additionally, IPF levels may help differentiate between ACS subtypes. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Mean Platelet Volume and Major Adverse Cardiac Events Following Percutaneous Coronary Intervention, Archives of Iranian Medicine (2019)
2. Correlation of Platelet-To-Lymphocyte Ratio and Neutrophil-To-Lymphocyte Ratio With Thrombolysis in Myocardial Infarction Frame Count in St-Segment Elevation Myocardial Infarction, European Journal of Clinical Investigation (2017)
3. Prognostic Value of Mean Platelet Volume in Patients Undergoing Elective Percutaneous Coronary Intervention, Anadolu Kardiyoloji Dergisi (2015)
Experts (# of related papers)
View all Related Experts
Saeed Sadeghian (3)
Arash Jalali (3)
Other Related Docs
4. Sex Differences in Safety and Efficacy of Dual Antiplatelet Therapy Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, American Journal of Cardiology (2025)
5. Pattern of Platelet Indices in Hypertension: A Single-Centre Experience for a Primary Care Setting, Family Medicine and Primary Care Review (2023)
6. Analyzing Gensini Score As a Semi-Continuous Outcome, Journal of Tehran University Heart Center (2016)
7. Relationship Between Red Blood Cell Distribution Width and Mortality of Patients With Acute Myocardial Infarction Referring to Tehran Heart Center, Critical Pathways in Cardiology (2015)
8. Evaluating Mortality Rate and Associated Parameters in Patients With Acute Coronary Syndrome, Cardiovascular and Hematological Disorders - Drug Targets (2020)
9. Incidence of Endoscopic Findings and Related Risk Factors in Patients With Gastrointestinal Bleeding After Percutaneous Coronary Intervention and Combination Antiplatelet Therapy, Govaresh (2016)
10. The Role of Ffr in Clinical Decision Making in Patients With Moderate Coronary Lesions: A Pilot Study, Acta Biomedica (2018)
11. Investigating the Refractory Platelet Transfusion: Understanding the Underlying Factors, Diagnosis, and Effective Treatment Strategies, Iranian Journal of Blood and Cancer (2025)
12. Effect of Baseline Red Blood Cell Distribution Width on Short-And Intermediate-Term Mortality of Patients Under Primary Percutaneous Coronary Intervention a Survival Analysis, Critical Pathways in Cardiology (2016)
13. Coronary Artery Disease Presentation and Its Association With Shortened Activated Partial Thromboplastin Time, Journal of Tehran University Heart Center (2018)
14. Prognostic Value of Fragmented Qrs Complex in Patients With Acute Myocardial Infarction; [Prognostische Bedeutung Des Fragmentierten Qrs-Komplexes Bei Patienten Mit Akutem Myokardinfarkt], Herz (2021)
15. Platelet Volume Parameters As Predictors of Valvular Thrombosis Risk in Patients With Aortic and Mitral Valve Replacement, Clinical and Applied Thrombosis/Hemostasis (2025)
16. Diagnostic Value of Electrocardiographic Indices in Discriminating the Culprit Vessel Based on the Coronary Dominancy in Inferior Acute Myocardial Infarction, Journal of Electrocardiology (2024)
17. Cardiovascular Risk Assessment by Frs and Score in Iranian Adult Population, Journal of Diabetes and Metabolic Disorders (2017)
18. Development of the First Iranian Clinical Practice Guidelines for the Diagnosis, Treatment, and Secondary Prevention of Acute Coronary Syndrome, Journal of Research in Medical Sciences (2024)
19. Validity and Diagnostic Performance of Computing Fractional Flow Reserve From 2-Dimensional Coronary Angiography Images, Texas Heart Institute Journal (2023)
20. Effects of Familial Hypercholesterolemia on Major Adverse Cardiac and Cerebrovascular Events in Patients With Premature Coronary Artery Disease: A Retrospective Cohort Study, Journal of Tehran University Heart Center (2025)